Fenk R - Search Results

1

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.

Goldschmidt H, Mai EK, Bertsch U, Fenk R, Nievergall E, Tichy D, Besemer B, Dürig J, Schroers R, von Metzler I, Hänel M, Mann C, Asemissen AM, Heilmeier B, Weinhold N, Huhn S, Kriegsmann K, Luntz SP, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Khandanpour C, Knauf W, Scheid C, Munder M, Geer T, Riesenberg H, Thomalla J, Hoffmann M, Raab MS, Salwender HJ, Weisel KC; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators. Goldschmidt H, et al. Among authors: fenk r. Lancet Haematol. 2022 Nov;9(11):e810-e821. doi: 10.1016/S2352-3026(22)00263-0. Lancet Haematol. 2022. PMID: 36328040 Clinical Trial.

2

Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer.

Rohr UP, Rehfeld N, Pflugfelder L, Geddert H, Müller W, Steidl U, Fenk R, Gräf T, Schott M, Thiele KP, Gabbert HE, Germing U, Kronenwett R, Haas R. Rohr UP, et al. Among authors: fenk r. Int J Cancer. 2004 Aug 20;111(2):259-63. doi: 10.1002/ijc.20252. Int J Cancer. 2004. PMID: 15197780 Free article.

3

Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera.

Steidl U, Schroeder T, Steidl C, Kobbe G, Graef T, Bork S, Pechtel S, Kliszewski S, Kuendgen A, Rohr UP, Fenk R, Schroeder M, Haase D, Haas R, Kronenwett R. Steidl U, et al. Among authors: fenk r. Ann N Y Acad Sci. 2005 Jun;1044:94-108. doi: 10.1196/annals.1349.013. Ann N Y Acad Sci. 2005. PMID: 15958702 Review.

4

Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.

Rohr UP, Rehfeld N, Geddert H, Pflugfelder L, Bruns I, Neukirch J, Rohrbeck A, Grote HJ, Steidl U, Fenk R, Opalka B, Gabbert HE, Kronenwett R, Haas R. Rohr UP, et al. Among authors: fenk r. Clin Cancer Res. 2005 Jan 1;11(1):180-5. Clin Cancer Res. 2005. PMID: 15671544

5

Myasthenia gravis: selective enrichment of antiacetylcholine receptor antibody production in untransformed human B cell cultures.

Padberg F, Matsuda M, Fenk R, Patenge N, Kubuschok B, Hohlfeld R, Wekerle H, Spuler S. Padberg F, et al. Among authors: fenk r. Eur J Immunol. 1999 Nov;29(11):3538-48. doi: 10.1002/(SICI)1521-4141(199911)29:11<3538::AID-IMMU3538>3.0.CO;2-Y. Eur J Immunol. 1999. PMID: 10556808 Free article.

6

[Rare types of vasculitis as markers of plasmocytoma].

Marini A, Fenk R, Plettenberg H, Ruzicka T, Haas R, Hengge UR. Marini A, et al. Among authors: fenk r. Hautarzt. 2006 Feb;57(2):137-43. doi: 10.1007/s00105-004-0890-5. Hautarzt. 2006. PMID: 15657729 German.

7

The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer.

Rehfeld N, Geddert H, Atamna A, Rohrbeck A, Garcia G, Kliszewski S, Neukirchen J, Bruns I, Steidl U, Fenk R, Gabbert HE, Kronenwett R, Haas R, Rohr UP. Rehfeld N, et al. Among authors: fenk r. J Carcinog. 2006 Jan 20;5:4. doi: 10.1186/1477-3163-5-4. J Carcinog. 2006. PMID: 16426442 Free PMC article.

8

Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.

Rohr UP, Wulf MA, Stahn S, Heyd F, Steidl U, Fenk R, Opalka B, Pitschke G, Prisack HB, Bojar H, Haas R, Kronenwett R. Rohr UP, et al. Among authors: fenk r. Cancer Gene Ther. 2003 Dec;10(12):898-906. doi: 10.1038/sj.cgt.7700643. Cancer Gene Ther. 2003. PMID: 14712316

9

Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma.

Papewalis C, Fassnacht M, Willenberg HS, Domberg J, Fenk R, Rohr UP, Schinner S, Bornstein SR, Scherbaum WA, Schott M. Papewalis C, et al. Among authors: fenk r. Clin Endocrinol (Oxf). 2006 Aug;65(2):215-22. doi: 10.1111/j.1365-2265.2006.02576.x. Clin Endocrinol (Oxf). 2006. PMID: 16886963

10

Quantitative real-time PCR for titration of infectious recombinant AAV-2 particles.

Rohr UP, Heyd F, Neukirchen J, Wulf MA, Queitsch I, Kroener-Lux G, Steidl U, Fenk R, Haas R, Kronenwett R. Rohr UP, et al. Among authors: fenk r. J Virol Methods. 2005 Jul;127(1):40-5. doi: 10.1016/j.jviromet.2005.03.006. Epub 2005 Apr 12. J Virol Methods. 2005. PMID: 15893564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page